Solriamfetol Clinical Trials (2026): 19 Studies for Obstructive Sleep Apnea & Excessive Sleepiness

Where to Participate: All Solriamfetol Trial Sites in the U.S. (92 sites across 23 states)

Every actively recruiting Solriamfetoltrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Solriamfetol clinical trials at a glance: phase × recruitment status

Recruiting Solriamfetol clinical trials (7)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Solriamfetol clinical trials by indication

Solriamfetol pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Terminated and withdrawn Solriamfetol trials (1)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT04788953terminatedClinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

All Solriamfetol trials (19)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Solriamfetol clinical trials: frequently asked questions

How many Solriamfetol clinical trials are there?

19 Solriamfetol clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 6 are actively recruiting participants. 10 are marked completed.

Are Solriamfetol clinical trials recruiting in 2026?

Yes — 6 Solriamfetol trials are actively recruiting in 2026, with 92 U.S. sites across 23 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Solriamfetol being studied for?

Solriamfetol is being studied for Obstructive Sleep Apnea, Excessive Sleepiness, Narcolepsy, Long COVID-19, Hypersomnia and 21 more. The trials are grouped by indication on this page.

What phase is Solriamfetol in?

Solriamfetol clinical trials span 5 Phase 4, 7 Phase 3, 4 Phase 2, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Solriamfetol clinical trials?

The lead sponsor across the most Solriamfetol trials is Axsome Therapeutics, Inc., with 9 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Solriamfetolas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.